• There are no suggestions because the search field is empty.
  • Careers
  • Media
  • Investors
  • Contact us
Company
Company
Purpose
Strategy
Leadership
History
Locations
Offering
Offering
Drug Substances
Exclusive synthesis API portfolio Reference standards Preclinical and early-phase development Alkaloid raw materials extraction
Drug Products
Oral solid dosage forms Sterile injectables Ophthalmics Inhalation products Viral vectors
Technologies
Sustainability
Sustainability
People
Environment
Integrity
Quality
Community engagement
Risk management
Insights

What are you
looking for?

Company
Purpose
Strategy
Leadership
History
Locations
Offering
Drug Substances
Exclusive synthesis API portfolio Reference standards Preclinical and early-phase development Alkaloid raw materials extraction
Drug Products
Oral solid dosage forms Sterile injectables Ophthalmics Inhalation products Viral vectors
Technologies
Sustainability
People
Environment
Integrity
Quality
Community engagement
Risk management
Insights
  • Careers
  • Media
  • Investors
  • Contact us

Insights

See our event recap

Filter by tags
Technology Early-phase development Sustainability Drug Products Regulatory support
Technology Early-phase development Sustainability Drug Products Regulatory support Oral solid dosage form Scale-up Dosage Form Fill-finish Pharmaceutical Manufacturing Pre-filled syringes
NEW
07/10/2025
Early-phase development

Accelerate drug development with phase-appropriate thinking

Read article
Recent
Sep 28, 2026
Drug Products Oral solid dosage form

Accelerating early-stage CMC development for oral drug products

Aug 19, 2026
Early-phase development Regulatory support

More than compliance: Managing the challenges of controlled substance manufacturing

Jul 23, 2026
Scale-up Drug Products

Dosage form scale-up: Balancing speed and efficiency in later-stage development

Subscribe for more expert insights

 

All posts
Jul 10, 2025
Early-phase development

Accelerate drug development with phase-appropriate thinking

Mar 21, 2025
Early-phase development

Ask better, move faster: Questions that will accelerate the speed of your program to clinical

Oct 30, 2025

Video: Insights from Chief Scientific Officer Stefan Randl at CPHI Frankfurt 2025

Sign up to stay up to date on Siegfried and our business performance.

expect more

Siegfried AG

Untere Brühlstrasse 4
4800 Zofingen, Switzerland
+41 62 746 11 11 Get in touch

About us

  • Our company
  • Sustainability
  • Media
  • Investors
  • Careers

Helpful resources

  • Expert insights
  • News archive
  • Reports
  • Terms and conditions

Offering

  • Drug Substances
  • Drug Products
  • Technologies

2026 © Siegfried Holding AG

  • Privacy Policy
  • Legal disclaimer
  • Imprint